Rapport Therapeutics News

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-ARCH Venture Fund XII, L.P.(10.2%),ARCH Venture Partners XII, L.P.(10.2%), etc.

Nov 15, 2024 06:17

Rapport Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%)

Nov 15, 2024 04:16

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Capital International Investors(7.1%)

Nov 14, 2024 01:32

Rapport Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Nov 12, 2024 23:42

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Wendy B.

Nov 8, 2024 08:03

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PEREZ ROBERT J

Nov 8, 2024 08:03

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Silva Paul M

Nov 8, 2024 08:03

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sanchez Ramiro

Nov 8, 2024 07:48

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director PEREZ ROBERT J

Nov 8, 2024 07:48

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Silva Paul M

Nov 8, 2024 07:38

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Sanchez Ramiro

Nov 8, 2024 07:33

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Young Wendy B.

Nov 8, 2024 07:28

Rapport Therapeutics | 10-Q: Quarterly report

Nov 7, 2024 20:33

Rapport Therapeutics | 8-K: Current report

Nov 7, 2024 20:18

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Johnson & Johnson(6.8%),Johnson & Johnson Innovation-JJDC, Inc.(6.8%)

Oct 19, 2024 05:25

Rapport Therapeutics | 10-Q: Quarterly report

Aug 8, 2024 19:44

Rapport Therapeutics | 8-K: Current report

Aug 8, 2024 19:24

Rapport Therapeutics | SEC STAFF LETTER: Others

Jul 27, 2024 03:53

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(13.624%),Abigail P. Johnson(13.624%)

Jul 10, 2024 22:15

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES

Jul 4, 2024 08:06